Neganova, M.; Aleksandrova, Y.; Suslov, E.; Mozhaitsev, E.; Munkuev, A.; Tsypyshev, D.; Chicheva, M.; Rogachev, A.; Sukocheva, O.; Volcho, K.;
et al. Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation. Pharmaceutics 2021, 13, 1893.
https://doi.org/10.3390/pharmaceutics13111893
AMA Style
Neganova M, Aleksandrova Y, Suslov E, Mozhaitsev E, Munkuev A, Tsypyshev D, Chicheva M, Rogachev A, Sukocheva O, Volcho K,
et al. Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation. Pharmaceutics. 2021; 13(11):1893.
https://doi.org/10.3390/pharmaceutics13111893
Chicago/Turabian Style
Neganova, Margarita, Yulia Aleksandrova, Evgenii Suslov, Evgenii Mozhaitsev, Aldar Munkuev, Dmitry Tsypyshev, Maria Chicheva, Artem Rogachev, Olga Sukocheva, Konstantin Volcho,
and et al. 2021. "Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation" Pharmaceutics 13, no. 11: 1893.
https://doi.org/10.3390/pharmaceutics13111893
APA Style
Neganova, M., Aleksandrova, Y., Suslov, E., Mozhaitsev, E., Munkuev, A., Tsypyshev, D., Chicheva, M., Rogachev, A., Sukocheva, O., Volcho, K., & Klochkov, S.
(2021). Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation. Pharmaceutics, 13(11), 1893.
https://doi.org/10.3390/pharmaceutics13111893